HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sadao Aoki Selected Research

Multi-centric Castleman's Disease

5/2022TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
8/2021Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndrome.
1/2021Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
3/2019An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
1/2019Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
1/2018The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
6/2016Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sadao Aoki Research Topics

Disease

8Thrombocytopenia (Thrombopenia)
05/2022 - 01/2018
7Multi-centric Castleman's Disease
05/2022 - 06/2016
7Fever (Fevers)
05/2022 - 01/2018
7Edema (Dropsy)
05/2022 - 01/2018
5Lymphoma (Lymphomas)
09/2008 - 07/2002
4Fibrosis (Cirrhosis)
05/2022 - 01/2018
3Castleman Disease (Castleman's Disease)
03/2022 - 01/2018
3Primary Myelofibrosis (Myelosclerosis)
08/2021 - 01/2019
3Renal Insufficiency (Renal Failure)
10/2019 - 01/2018
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2018 - 07/2005
3Disease Progression
02/2013 - 03/2003
2Leukemia
09/2017 - 02/2002
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2013 - 07/2005
2Neoplasms (Cancer)
09/2008 - 05/2005
2Hodgkin Disease (Hodgkin's Disease)
09/2006 - 07/2005
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2005 - 02/2002
2Multiple Myeloma
07/2005 - 05/2005
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
03/2019
1Hypoalbuminemia
01/2019
1Anemia
01/2019
1Neutropenia
10/2018
1Hemolysis
09/2018
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
09/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2017
1Myeloid Sarcoma (Chloroma)
09/2017
1Febrile Neutropenia
02/2011
1T-Cell Leukemia (Leukemia, T Cell)
12/2007
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2007
1Cardiotoxicity
01/2007
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
07/2005
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2005
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2005
1Burkitt Lymphoma (Burkitt's Lymphoma)
07/2005
1Hypercalcemia (Milk Alkali Syndrome)
05/2005
1Chromosome Aberrations (Chromosome Abnormalities)
03/2003
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2003
1monosomy Chromosome 7
03/2003
1Necrosis
07/2002
1Dyspnea (Shortness of Breath)
07/2002

Drug/Important Bio-Agent (IBA)

7Reticulin (Reticular Fiber)IBA
05/2022 - 01/2018
5Interleukin-6 (Interleukin 6)IBA
03/2022 - 02/2013
3Rituximab (Mabthera)FDA Link
09/2018 - 10/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2006 - 05/2005
2fibrin fragment D (D-dimer)IBA
08/2021 - 07/2002
2tocilizumab (atlizumab)FDA Link
06/2016 - 01/2013
2Vincristine (Oncovin)FDA LinkGeneric
09/2006 - 06/2006
2Etoposide (VP 16)FDA LinkGeneric
09/2006 - 06/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
09/2006 - 06/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2006 - 06/2006
1C-Reactive ProteinIBA
01/2019
1Interleukin-2 Receptors (IL 2 Receptor)IBA
10/2018
1ibrutinibIBA
09/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
09/2018
1Azacitidine (5 Azacytidine)FDA Link
09/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2016
1GlucocorticoidsIBA
06/2016
1Monoclonal AntibodiesIBA
05/2015
1Alemtuzumab (Campath)FDA Link
05/2015
1ofatumumabFDA Link
05/2015
1SteroidsIBA
01/2013
1biapenem (L 627)IBA
02/2011
1Anti-Bacterial Agents (Antibiotics)IBA
02/2011
1Carbapenems (Carbapenem Antibiotics)IBA
02/2011
1Proteins (Proteins, Gene)FDA Link
09/2008
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2007
1Procarbazine (Matulane)FDA Link
09/2006
1Prednisolone (Predate)FDA LinkGeneric
09/2006
1Prednisone (Sone)FDA LinkGeneric
06/2006
1A 7 (A-7)IBA
07/2005
1Alkylating AgentsIBA
05/2005
1CalciumIBA
05/2005
1ThrombomodulinIBA
07/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2002
1AntigensIBA
02/2002

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2013 - 02/2002
3Therapeutics
06/2006 - 03/2003
1Transplantation
12/2007
1PACEBO protocol
12/2006
1Stem Cell Transplantation
05/2005
1Continuous Passive Motion Therapy
05/2005
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
03/2003
1Combination Drug Therapy (Combination Chemotherapy)
03/2003